Triglimisave 1 Tablet SR
Marketer
Eris Lifesciences Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Triglimisave 1 Tablet SR
Diabetol SR 1mg, a combined formulation, effectively manages blood glucose. In conjunction with diet and exercise, it enhances glycemic control in adult patients with type 2 diabetes. This medication facilitates improved insulin utilization, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Take with food to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your normal schedule. Never double the dose; overdose can cause hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is essential. Common adverse effects include nausea, diarrhea, abdominal pain, headache, increased bone fracture risk, and respiratory infections. Disclose any pre-existing kidney, liver, or heart conditions to your doctor prior to commencing treatment. Pregnant or lactating women should consult their doctor before use. Baseline kidney function tests will be conducted before treatment initiation. Limit alcohol consumption as it may exacerbate adverse effects.
Primary Ingredients of Triglimisave 1 Tablet SR
No text provided. Please provide the text you would like me to rephrase.
Uses of Triglimisave 1 Tablet SR
Managing type 2 diabetes
Major Benefits of Triglimisave 1 Tablet SR:
Consume Triglimisave 1 Tablet SR precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or breaking it. It should be taken with a meal.
Common Side effects of Triglimisave 1 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Triglimisave 1 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Triglimisave 1 SR Tablet with a meal.
How Triglimisave 1 Tablet SR works:
Triglimisave SR, a single-tablet formulation, combines glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications employ diverse mechanisms to achieve superior blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further amplifies insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triglimisave 1 Tablet SR and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Triglimisave 1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against possible risks prior to prescribing this medication. Seek medical advice before taking this drug.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Triglimisave tablet (1mg) is likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Triglimisave 1 Tablet SR cautiously, potentially requiring dosage modification. Consultation with a physician is necessary. Triglimisave 1 Tablet SR is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Triglimisave 1 Tablet SR cautiously, potentially requiring a modified dosage. Consult your physician for guidance. Triglimisave 1 Tablet SR is contraindicated in individuals with advanced liver disease.
What if you forget to take Triglimisave 1 Tablet SR :
Should you forget to take a Triglimisave 1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triglimisave 1 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |





